Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lannett Company Inc (NYSE:LCI)

24.20
Delayed Data
As of Dec 02
 +0.60 / +2.54%
Today’s Change
16.75
Today|||52-Week Range
44.49
-39.68%
Year-to-Date

Today’s Trading

Previous close23.60
Today’s open23.80
Day’s range23.60 - 25.20
Volume884,415
Average volume (3 months)1,132,284
Market cap$895.4M
Dividend yield--
Data as of 4:01pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-70.30%
Earnings growth (this year)-1.02%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+39.14%
P/E ratioNM
Price/Sales1.57
Price/Book1.60

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.05+0.63%
MGNXMacroGenics Inc+1.96+8.06%
AMPHAmphastar Pharmaceut...+0.52+2.64%
FWPForward Pharma A/S-0.44-2.45%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.85
Annual revenue (last year)$566.1M
Annual profit (last year)$44.8M
Net profit margin7.91%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
CFO, Treasurer &
Vice President-Finance
Martin P. Galvan
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts


Search for Jobs